2010 AAO-MEACO meeting focuses on genetic medicine Oct.

It is the largest, most extensive ophthalmic education conference in the global world. Seeking Genetics-Specific Remedies for Age-Related Macular Degeneration In the past decade ophthalmologists gained a robust tool to control vision-damaging ‘wet’ age-related macular degeneration : anti-vascular endothelial growth factor medications. Anti-VEGF drugs halt or reverse damage in many wet AMD patients also, but some do not respond as well to treatment therefore suffer severe vision loss. The brand new field of pharmacogenetics seeks to enable doctors to individualize treatment based on the patient’s genetic account for a disease. In a collaborative effort, the Hussman Institute for Individual Genomics and Bascom Palmer Eyesight Institute at the University of Miami Miller School of Medicine studied whether particular genetic AMD risk elements and/or smoking influenced individuals’ responses to anti-VEGF treatment.The findings were presented today at the 37th Annual Conference and International Meeting of the Association for Professionals in Infections Control and Epidemiology . Methodist Dallas INFIRMARY identified a unique cluster of drug-resistant Acinetobacter during a one-week period in ’09 2009 and conducted an immediate investigation. Through quick response and extensive interventions, the hospital was able to arrest the outbreak in a very much shorter time-frame compared with most other reported outbreaks of this bacterium that have been known to last for a few months or years. Disease control staff at the 515-bed hospital, in discussion with a healthcare facility Epidemiologist, Dr. Zakir Shaikh, quickly concluded that the known cases met the criteria for full epidemiological investigation and started an aggressive marketing campaign of surveillance and intervention.